Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

PAOD - Peripheral Arterial Occlusive Disease Clinical Trial

— AOMI  

Official title:

Study of the Prevalence of Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05149456
• Other study ID #: 8373
• Status: Recruiting
• Start date: August 15, 2021
• Est. completion date: August 31, 2022

Study information

• Verified date: November 2021
• Source: University Hospital, Strasbourg, France
• Contact: Dominique STEPHAN, MD, PhD
• Phone: 33 3 69 55 09 52
• Email: dominique.stephan[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The cardiovascular risk of women has been the subject of particular interest in recent years, in the world, in particular under the impetus of Cardiology companies, with more and more work focusing on the specificities of these diseases in women as well as differences in terms of management and prognosis with a literature mainly based on American data and which focuses particularly on ischemic heart disease. The expected results are to have a prevalence of PAOD in an Alsatian cohort, most of the data we currently have from American data, with analysis of the impact of specific and non-specific risk factors in this cohort and their weight in PAOD.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: August 31, 2022
• Est. primary completion date: August 2022
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Adult woman (=18 years old)
• Patient hospitalized in an Intensive Cardiology Unit (ICU) at the HUS for a type 1 myocardial infarction confirmed according to the criteria of the fourth universal definition of the ESC between 01/01/2021 to 30/06/2021 inclusive
• Patient who did not express her opposition to the reuse of her data for scientific research purposes.

Exclusion criteria:

• Patient who expressed her opposition to participating in the study
• Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, MMS <20/30…)
• Non-type 1 or unconfirmed myocardial infarction
• Unstable or refractory shock state at the time of the echodoppler examination
• Complication of the coronary angiography approach, in the case of femoral approach only, requiring surgical management.
• Patient under curatorship, guardianship or judicial safeguard.

Related Conditions & MeSH terms

• Arterial Occlusive Diseases
• Infarction
• Myocardial Infarction
• PAOD - Peripheral Arterial Occlusive Disease
• Peripheral Arterial Disease

Locations

Country	Name	City	State
France	Service des Maladies VASC-HTA-Pharmacologie Clinique - Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Study of the prevalence of peripheral artery occlusive disease (PAOD)		Files analysed retrospectively from January 01, 2021 to Jun 30, 2021 will be examined]